GI safety of OTC ibuprofen
This article was originally published in The Tan Sheet
Executive Summary
Whitehall-Robins' clinical trial in 234 subjects aged 65 or older indicates that the gastrointestinal safety profile of Advil is similar to placebo, according to results presented at the American College of Gastroenterology annual scientific meeting in Boston on Oct. 12. The subjects were a subset of a larger study involving 1,246 subjects comparing the GI safety profile of two Advil formulations: the new liqui-gel and a film-coated tablet. There were "no significant differences" between the treatment groups and placebo in terms of adverse events including dyspepsia, diarrhea, abdominal pain, nausea and intestinal ulceration, the study by Geraldine Doyle, PhD, et al. found